Clinical trial
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
NCT01913548 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
- Lead sponsor
- UCSF Benioff Children's Hospital Oakland
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- October 31, 2013
- Enrollment
- 423 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diamond-blackfan anemia, sickle cell disease, thalassemia